University Of California, Santa Barbara
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1891-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.ucsb.edu
Advancements in CGB-500 for Atopic Dermatitis Treatment
CAGE Bio Inc. is making strides in dermatological drug development with its ionic liquid formulation, CGB-500, showing promising results in clinical trials for atopic dermatitis. The company's CEO, Nitin Joshi, PhD, shared insights into the development process and the potential of this innovative treatment approach.
© Copyright 2025. All Rights Reserved by MedPath